NASHVILLE, Tenn., Jan. 27, 2026 /PRNewswire/ — Arcline Investment Management (“Arcline”), a growth-oriented private equity firm, today announced that it has enteredNASHVILLE, Tenn., Jan. 27, 2026 /PRNewswire/ — Arcline Investment Management (“Arcline”), a growth-oriented private equity firm, today announced that it has entered

Arcline to Sell Resolution Medical to Resonetics

2026/01/28 03:32
2 min read

NASHVILLE, Tenn., Jan. 27, 2026 /PRNewswire/ — Arcline Investment Management (“Arcline”), a growth-oriented private equity firm, today announced that it has entered into a definitive agreement to sell its portfolio company Resolution Medical to Resonetics.

Based in Fridley, Minnesota, Resolution Medical is a scaled, end-to-end engineering services and outsourced manufacturing partner focused on complex Class II and III devices for the most disruptive medical technology end markets including structural heart, cardiology and vascular, electrophysiology, and neuromodulation therapies. With 240 employees, more than 100 of whom are world-class engineers, Resolution Medical provides expertise in device design, prototyping, bio-simulation, and product design, through to finished device manufacturing. 

Peter Herman, CEO of Resolution Medical, commented, “With Arcline’s support, Resolution Medical has become a leader in the development and commercialization of cutting edge medical devices in the fastest-growing therapeutic modalities. We look forward to joining the Resonetics team and continuing our mission of supporting the most innovative technologies in interventional medicine to save lives and improve patient outcomes.”

“Resolution Medical is an exceptional organization with deep technical expertise, a strong innovation culture, and a proven track record in designing and developing complex medical devices for the most innovative companies,” said Kevin Kelly, CEO of Resonetics. “This acquisition enhances our ability to deliver fully integrated solutions for customers in high-growth markets like neuromodulation and structural heart, and supports our vision of becoming the most comprehensive partner in the medical device industry.”

The acquisition is expected to close in the first quarter of 2026, subject to regulatory approvals and customary closing conditions.

Piper Sandler & Co. served as financial advisor, and Bass, Berry & Sims PLC and Fredrikson & Byron P.A. served as legal advisors to Resolution Medical in connection with the transaction.

About Arcline Investment Management
Arcline Investment Management is a growth-oriented private equity firm with over $20 billion in assets under management. Arcline seeks to build the next generation of Industrial Compounders – market-leading, non-disruptible industrial platforms designed to consistently grow earnings over decades. For more information visit www.arcline.com.

Contact Information:
contact@arcline.com
www.arcline.com

Contact (For Press Inquiries Only):

Tim Ragones / Alexander Wolfsohn
Joele Frank, Wilkinson Brimmer Katcher
Arcline-JF@joelefrank.com
(212) 355-4449

Cision View original content:https://www.prnewswire.com/news-releases/arcline-to-sell-resolution-medical-to-resonetics-302671626.html

SOURCE Arcline Investment Management

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

SON DAKİKA: SEC, Ethereum (ETH) İçin Beklenen ETF Onayını Verdi!

SON DAKİKA: SEC, Ethereum (ETH) İçin Beklenen ETF Onayını Verdi!

ABD Menkul Kıymetler ve Borsa Komisyonu (SEC), Grayscale’in Ethereum Trust ETF ve Ethereum Mini Trust ETF ürünlerini yeni kabul edilen “genel listeleme” (generic listing) çerçevesi altında onayladı. 23 Eylül 2025 tarihli açıklamaya göre, New York Menkul Kıymetler Borsası Arca (NYSE Arca), her iki ETF’nin de artık Rule 8.201-E (Generic) standardına göre işlem görebileceğini bildirdi. Daha […] Kaynak: Bitcoinsistemi.com
Share
Coinstats2025/09/24 02:37
Altcoins Poised to Benefit from SEC’s New ETF Listing Standards

Altcoins Poised to Benefit from SEC’s New ETF Listing Standards

The post Altcoins Poised to Benefit from SEC’s New ETF Listing Standards appeared on BitcoinEthereumNews.com. On Wednesday, the US SEC (Securities and Exchange Commission) took a landmark step in crypto regulation, approving generic listing standards for spot crypto ETFs (exchange-traded funds). This new framework eliminates the case-by-case 19b-4 approval process, streamlining the path for multiple digital asset ETFs to enter the market in the coming weeks. Grayscale’s Multi-Crypto Milestone Sponsored Grayscale secured a first-mover advantage as its Digital Large Cap Fund (GDLC) received approval under the new listing standards. Products that will be traded under the ticker GDLC include Bitcoin, Ethereum, XRP, Solana, and Cardano. “Grayscale Digital Large Cap Fund $GDLC was just approved for trading along with the Generic Listing Standards. The Grayscale team is working expeditiously to bring the FIRST multi-crypto asset ETP to market with Bitcoin, Ethereum, XRP, Solana, and Cardano,” wrote Grayscale CEO Peter Mintzberg. The approval marks the US’s first diversified, multi-crypto ETP, signaling a shift toward broader portfolio products rather than single-asset ETFs. Bloomberg’s Eric Balchunas explained that around 12–15 cryptocurrencies now qualify for spot ETF consideration. However, this is contingent on the altcoins having established futures trading on Coinbase Derivatives for at least six months. Sponsored This includes well-known altcoins like Dogecoin (DOGE), Litecoin (LTC), and Chainlink (LINK), alongside the majors already included in Grayscale’s GDLC. Altcoins in the Spotlight Amid New Era of ETF Eligibility Several assets have already met the key condition, regulated futures trading on Coinbase. For example, Solana futures launched in February 2024, making the token eligible as of August 19. “The SEC approved generic ETF listing standards. Assets with a regulated futures contract trading for 6 months qualify for a spot ETF. Solana met this criterion on Aug 19, 6 months after SOL futures launched on Coinbase Derivatives,” SolanaFloor indicated. Sponsored Crypto investors and communities also identified which tokens stand to gain. Chainlink…
Share
BitcoinEthereumNews2025/09/18 13:46
Hadron Labs Launches Bitcoin Summer on Neutron, Offering 5–10% BTC Yield

Hadron Labs Launches Bitcoin Summer on Neutron, Offering 5–10% BTC Yield

Hadron Labs launches 'Bitcoin Summer' on Neutron, BTC vaults for WBTC, eBTC, solvBTC, uniBTC and USDC. Earn 5–10% BTC via maxBTC, with up to 10x looping.
Share
Blockchainreporter2025/09/18 02:00